Angiodynamics (ANGO) Operating Expenses (2010 - 2026)

Angiodynamics (ANGO) has reported Operating Expenses for 17 consecutive years, with $57.0 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Operating Expenses rose 18.67% year-over-year to $57.0 million; the trailing twelve-month figure through May 2026 stood at $214.8 million (up 8.68% YoY), and the FY2026 full-year result was $214.8 million, up 8.68% from the prior year.
• Operating Expenses rose to $57.0 million in Q2 2026 per ANGO's latest filing, from $54.4 million in the prior quarter.
• Across five years, Operating Expenses topped out at $242.4 million in Q1 2024 and bottomed at $43.9 million in Q1 2022.
• Historically, Operating Expenses has averaged $63.1 million across 5 years, with a median of $52.9 million in 2022.
• The sharpest annual moves came in 2024 and 2025: Operating Expenses soared 390.4% in 2024, then tumbled 79.86% in 2025.
• Over 5 years, Operating Expenses stood at $53.2 million in 2022, then climbed by 0.36% to $53.4 million in 2023, then fell by 4.46% to $51.0 million in 2024, then dropped by 0.18% to $50.9 million in 2025, then advanced by 11.9% to $57.0 million in 2026.
• According to Business Quant data, Operating Expenses over the past three periods registered $57.0 million, $54.4 million, and $50.9 million for Q2 2026, Q1 2026, and Q4 2025 respectively.